NCT03883633View on ClinicalTrials.gov

Reversal of Cognitive Decline (ReCODE) Study

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Alzheimer DiseaseMild Cognitive Impairment
Interventions
BEHAVIORAL

ReCODE Protocol

Functional medicine approach to address symptoms of Alzheimer's and cognitive decline

Trial Locations (3)

94597

Bay Area Wellness, Walnut Creek

94903

Ann Hathaway MD, San Rafael

97520

Northwest Memory Center, Ashland

All Listed Sponsors
lead

QuesGen Systems Inc

OTHER

NCT03883633 - Reversal of Cognitive Decline (ReCODE) Study | Biotech Hunter | Biotech Hunter